Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment
Article in Frontiers in Immunology (January 2023)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients
Article in Frontiers in Microbiology (August 2022)
Combination and Intermittent Therapy Based on Pegylated Interferon Alfa-2a for Chronic Hepatitis B with Nucleoside (Nucleotide) Analog-Experienced Resulting in Hepatitis B Surface Antigen Clearance: A Case Report
Article in Viral Immunology (October 2021)